Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.

[1]  Anne Floquet,et al.  Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. , 2017, The Lancet. Oncology.

[2]  D. Matei,et al.  Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. , 2016, The Lancet. Oncology.

[3]  N. Rahman,et al.  The integration of BRCA testing into oncology clinics. , 2016, British journal of nursing.

[4]  N. Pachter,et al.  Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing , 2016, International Journal of Gynecologic Cancer.

[5]  B. Monk,et al.  A randomized, double-blind phase III trial of niraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy. , 2016 .

[6]  B. Karlan,et al.  Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine. , 2016, JAMA.

[7]  S. Seal,et al.  Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients , 2016, Scientific Reports.

[8]  J. Abraham,et al.  Understanding of BRCA VUS genetic results by breast cancer specialists , 2015, BMC Cancer.

[9]  E. Smets,et al.  Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer , 2015, Familial Cancer.

[10]  P. Bruzzi,et al.  Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement , 2015, Public Health Genomics.

[11]  C. Scott,et al.  Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Robison,et al.  Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. , 2012, Gynecologic oncology.

[13]  Sokbom Kang,et al.  Completeness of pedigree and family cancer history for ovarian cancer patients , 2014, Journal of gynecologic oncology.

[14]  P. DiSilvestro,et al.  SOLO1 and SOLO2: Randomized phase III trials of olaparib in patients (pts) with ovarian cancer and a BRCA1/2 mutation (BRCAm). , 2014 .

[15]  J. Garber,et al.  Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Vogel,et al.  Genetic Risk Assessment for Women with Epithelial Ovarian Cancer: Referral Patterns and Outcomes in a University Gynecologic Oncology Clinic , 2013, Journal of Genetic Counseling.

[17]  M. Friedlander,et al.  Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing. , 2013, Oncology nursing forum.

[18]  J. George,et al.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Matei,et al.  Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. , 2012, The New England journal of medicine.

[20]  B. Meiser,et al.  There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer. , 2012, Gynecologic oncology.

[21]  L. Wilkins-Haug,et al.  Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health. , 2000, Journal of women's health & gender-based medicine.

[22]  J. Rogers,et al.  The semi-structured genogram interview. I: Protocol. II: Evaluation. , 1984 .